Ligand validation:6F2I

7MT: Tb-Xo4

7MT is a Ligand Of Interest in 6F2I designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6F2I_7MT_A_202	90%	34%	0.105	0.99	1.17	1.41	2	2	0	0	100%	0.85
6F2I_7MT_A_203	73%	41%	0.154	0.983	1.06	1.24	2	3	0	0	100%	0.7
6F2J_7MT_A_205	98%	33%	0.074	0.995	1.11	1.51	2	4	0	0	100%	0.85
6TVY_7MT_A_304	63%	31%	0.166	0.962	1.33	1.41	2	4	0	0	100%	0.81
6FRO_7MT_A_208	32%	33%	0.137	0.813	1.09	1.54	2	9	0	0	97%	0.8217
8OWC_7MT_A_202	8%	34%	0.26	0.734	0.96	1.63	-	8	0	0	97%	0.58
6F2M_7MT_D_302	95%	21%	0.092	0.995	1.46	1.84	3	7	0	0	100%	0.8
6F2F_7MT_A_201	93%	23%	0.092	0.989	1.25	1.89	3	7	0	0	100%	0.8
6FRN_7MT_D_508	91%	36%	0.104	0.99	1.11	1.42	1	2	0	0	100%	1
8BPQ_7MT_A_402	90%	21%	0.107	0.992	1.43	1.9	4	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.